NVO
Novo Nordisk A/S
NYSE · Healthcare · Drug Manufacturers - General · DK
$46.43
−2.28%Forward multiples
Based on analyst estimates
- P/E forward
- 14.77x
- P/E 2026E
- 13.49x
- P/E 2027E
- 13.77x
- P/E 2028E
- 12.63x
- P/S forward
- 4.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- 11.38x
- PEG TTM
- 0.55x
- Price / book
- 6.02x
- Price / sales
- 4.05x
- Price / cash flow
- 10.02x
Enterprise value
- Enterprise value
- $222.1B
- EV / sales
- 4.33x
- EV / EBITDA
- 7.89x
- EV / EBIT
- 10.05x
- Market cap
- $207.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026